Prosecution Insights
Last updated: August 18, 2026

Examiner: LEVERETT, MARY CHANG

Tech Center 1600 • Art Units: 1672 1681 1682 1687

This examiner grants 61% of resolved cases

Performance Statistics

61.1%
Allow Rate
+1.1% vs TC avg
113
Total Applications
+22.9%
Interview Lift
1524
Avg Prosecution Days
Based on 95 resolved cases, 2023–2026

Rejection Statute Breakdown

39.8%
§101 Eligibility
8.2%
§102 Novelty
28.7%
§103 Obviousness
18.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18069110 OFF-TARGET PREDICTION METHOD FOR ANTIGEN-RECOGNITION MOLECULES BINDING TO MHC-PEPTIDE TARGETS Non-Final OA Regeneron Pharmaceuticals, Inc.
17898240 SYSTEMS AND METHODS FOR IDENTIFYING ADAPTIVE IMMUNE CELL CLONOTYPES Non-Final OA 10x Genomics, Inc.
17610788 ASSESSMENT OF MULTIPLE SIGNALING PATHWAY ACTIVITY SCORE IN AIRWAY EPITHELIAL CELLS TO PREDICT AIRWAY EPITHELIAL ABNORMALITY AND AIRWAY CANCER RISK Non-Final OA KONINKLIJKE PHILIPS N.V.
18157400 TECHNIQUES AND SYSTEM FOR PARAMETER SELECTION FOR ONBOARDING AND ONGOING MANAGEMENT OF PUMP USERS Non-Final OA INSULET CORPORATION
18174468 CALIBRATION SEQUENCES FOR NUCLEOTIDE SEQUENCING Non-Final OA Illumina, Inc.
17876481 TRANSFER LEARNING-BASED USE OF PROTEIN CONTACT MAPS FOR VARIANT PATHOGENICITY PREDICTION Non-Final OA ILLUMINA, INC.
18358001 GENE MODEL FOR JUDGING PROGNOSIS OF HEPATOCELLULAR CARCINOMA PATIENTS, CONSTRUCTION METHOD AND USE THEREOF Non-Final OA ZHEJIANG UNIVERSITY
17876065 SYSTEM AND METHOD FOR CONTROLLING CELL FUNCTIONING AND MOTILITY WITH THE AID OF A DIGITAL COMPUTER Non-Final OA XEROX CORPORATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month